Literature DB >> 1117429

Inhibitory actions of laxatives on motility and water and electrolyte transport in the gastrointestinal tract.

J J Stewart, T S Gaginella, W A Olsen, P Bass.   

Abstract

Castor oil and magnesium sulfate were studied for their effects on gastrointestinal contractile activity in vivo. Ricinoleic acid, the active ingredient in castor oil, magnesium sulfate and mannitol were studied and compared for their effects on net water and electrolyte absorption in vitro. Extraluminal strain gauge transducers were implanted in dogs and used to monitor the circular smooth muscle activity of the antrum, duodenum, ileum and colon after water, castor oil or a 30 percent solution of magnesium sulfate. Substances were tested during the interdigestive (fasted) and digestive (fed) states. Decreases in total activity were found for both cathartics in the antrum and ileum. Further analysis revealed that decreases in the ileum occurred primarily by a decrease in contractile rate, whereas antral decreases could be attributed primarily to a decrease in force per contraction. Proximal colonic activity tended to decrease after laxatives and feeding. The effects of ricinoleic acid, isotonic and hypertonic solutions of magnesium sulfate and mannitol on net water and electrolyte absorption were tested on everted segments of hamster jejunum. Sodium ricinoleate (2.0 mM) reduced net water transport by 48 percent (P smaller than .01). Magnesium sulfate, like mannitol, only reduced net water absorption when present as a component of a hypertonic mucosal solution. The results suggest that both inhibition of water absorption and reduced circular smooth muscle activity may be important factors in castor oil- and magnesium sulfate-induced catharsis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1117429

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Ricinoleic acid: current view of an ancient oil.

Authors:  T S Gaginella; S F Phillips
Journal:  Am J Dig Dis       Date:  1975-12

2.  Effects of intestinal secretagogues and distension on small bowel myoelectric activity in fasted and fed conscious dogs.

Authors:  J Da Cunha Melo; R W Summers; H H Thompson; D L Wingate; R Yanda
Journal:  J Physiol       Date:  1981-12       Impact factor: 5.182

3.  The inhibitory effects of alpha(2)-adrenoceptor agonists on gastrointestinal transit during croton oil-induced intestinal inflammation.

Authors:  O Pol; L Valle; I Ferrer; M M Puig
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

4.  The effects of sodium ricinoleate on small intestinal function and structure.

Authors:  W S Cline; V Lorenzsonn; L Benz; P Bass; W A Olsen
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

5.  Ricinoleic acid stimulation of active anion secretion in colonic mucosa of the rat.

Authors:  L C Racusen; H J Binder
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

6.  Myoelectrical activity and propulsion in the large intestine of fed and fasted rats.

Authors:  J P Ferré; Y Ruckebusch
Journal:  J Physiol       Date:  1985-05       Impact factor: 5.182

7.  Increased cell loss in the human jejunum induced by laxatives (ricinoleic acid, dioctyl sodium sulphosuccinate, magnesium sulphate, bile salts).

Authors:  J F Bretagne; N Vidon; C L'Hirondel; J J Bernier
Journal:  Gut       Date:  1981-04       Impact factor: 23.059

8.  Ricinoleic acid effect on the electrical activity of the small intestine in rabbits.

Authors:  J R Mathias; J L Martin; T W Burns; G M Carlson; R P Shields
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

9.  A unique distribution of laxative-induced spike potentials from the small intestine of the dog.

Authors:  W D Atchison; J J Stewart; P Bass
Journal:  Am J Dig Dis       Date:  1978-06

10.  Nitric oxide as a mediator of the laxative action of magnesium sulphate.

Authors:  A A Izzo; T S Gaginella; N Mascolo; F Capasso
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.